Annual EBIT:
$11.56M+$129.55M(+109.80%)Summary
- As of today, BCRX annual earnings before interest & taxes is $11.56 million, with the most recent change of +$129.55 million (+109.80%) on December 31, 2024.
- During the last 3 years, BCRX annual EBIT has risen by +$134.08 million (+109.44%).
- BCRX annual EBIT is now at all-time high.
Performance
BCRX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$29.59M-$195.00K(-0.65%)Summary
- As of today, BCRX quarterly earnings before interest & taxes is $29.59 million, with the most recent change of -$195.00 thousand (-0.65%) on September 30, 2025.
- Over the past year, BCRX quarterly EBIT has increased by +$21.90 million (+284.70%).
- BCRX quarterly EBIT is now -0.65% below its all-time high of $29.79 million, reached on June 30, 2025.
Performance
BCRX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$76.10M+$21.90M(+40.41%)Summary
- As of today, BCRX TTM earnings before interest & taxes is $76.10 million, with the most recent change of +$21.90 million (+40.41%) on September 30, 2025.
- Over the past year, BCRX TTM EBIT has increased by +$116.80 million (+286.95%).
- BCRX TTM EBIT is now at all-time high.
Performance
BCRX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
BCRX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +109.8% | +284.7% | +286.9% |
| 3Y3 Years | +109.4% | +269.6% | +149.3% |
| 5Y5 Years | +111.9% | +169.0% | +162.1% |
BCRX EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +108.0% | -0.7% | +163.9% | at high | +149.3% |
| 5Y | 5-Year | at high | +106.9% | -0.7% | +156.7% | at high | +141.9% |
| All-Time | All-Time | at high | +106.9% | -0.7% | +156.7% | at high | +141.9% |
BCRX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $29.59M(-0.7%) | $76.10M(+40.4%) |
| Jun 2025 | - | $29.79M(+40.3%) | $54.20M(+63.4%) |
| Mar 2025 | - | $21.23M(+570.9%) | $33.17M(+1404.4%) |
| Dec 2024 | $11.56M(+109.8%) | -$4.51M(-158.6%) | -$2.54M(+93.8%) |
| Sep 2024 | - | $7.69M(-12.2%) | -$40.70M(+32.5%) |
| Jun 2024 | - | $8.76M(+160.5%) | -$60.32M(+32.8%) |
| Mar 2024 | - | -$14.49M(+66.0%) | -$89.78M(+13.4%) |
| Dec 2023 | -$117.99M(+18.8%) | -$42.67M(-257.9%) | -$103.71M(+3.4%) |
| Sep 2023 | - | -$11.92M(+42.4%) | -$107.35M(+4.9%) |
| Jun 2023 | - | -$20.70M(+27.1%) | -$112.87M(+11.0%) |
| Mar 2023 | - | -$28.41M(+38.6%) | -$126.89M(+14.5%) |
| Dec 2022 | -$145.29M(-18.6%) | -$46.31M(-165.5%) | -$148.44M(+3.8%) |
| Sep 2022 | - | -$17.45M(+49.8%) | -$154.30M(+15.0%) |
| Jun 2022 | - | -$34.72M(+30.5%) | -$181.44M(-2.9%) |
| Mar 2022 | - | -$49.96M(+4.3%) | -$176.30M(+0.8%) |
| Dec 2021 | -$122.52M(+27.2%) | -$52.18M(-17.0%) | -$177.72M(-2.8%) |
| Sep 2021 | - | -$44.58M(-50.7%) | -$172.92M(-1.0%) |
| Jun 2021 | - | -$29.58M(+42.4%) | -$171.20M(+5.0%) |
| Mar 2021 | - | -$51.38M(-8.4%) | -$180.13M(-6.1%) |
| Dec 2020 | -$168.31M(-73.5%) | -$47.38M(-10.5%) | -$169.73M(-38.6%) |
| Sep 2020 | - | -$42.86M(-11.3%) | -$122.46M(-6.8%) |
| Jun 2020 | - | -$38.51M(+6.0%) | -$114.69M(-3.2%) |
| Mar 2020 | - | -$40.98M(>-9900.0%) | -$111.10M(-11.7%) |
| Dec 2019 | -$97.00M(-5.4%) | -$109.00K(+99.7%) | -$99.45M(+20.2%) |
| Sep 2019 | - | -$35.10M(-0.5%) | -$124.61M(-5.6%) |
| Jun 2019 | - | -$34.92M(-19.1%) | -$118.00M(-16.4%) |
| Mar 2019 | - | -$29.33M(-16.1%) | -$101.34M(-7.6%) |
| Dec 2018 | -$92.08M(-60.9%) | -$25.26M(+11.3%) | -$94.22M(-8.5%) |
| Sep 2018 | - | -$28.49M(-56.1%) | -$86.82M(-21.1%) |
| Jun 2018 | - | -$18.25M(+17.8%) | -$71.67M(-4.0%) |
| Mar 2018 | - | -$22.21M(-24.4%) | -$68.94M(-20.1%) |
| Dec 2017 | -$57.22M(-17.6%) | -$17.86M(-33.8%) | -$57.41M(-20.3%) |
| Sep 2017 | - | -$13.35M(+14.0%) | -$47.74M(-9.4%) |
| Jun 2017 | - | -$15.52M(-45.2%) | -$43.63M(-8.4%) |
| Mar 2017 | - | -$10.69M(-30.5%) | -$40.24M(+17.2%) |
| Dec 2016 | -$48.66M(-28.7%) | -$8.19M(+11.4%) | -$48.61M(-20.3%) |
| Sep 2016 | - | -$9.24M(+23.8%) | -$40.42M(+8.8%) |
| Jun 2016 | - | -$12.13M(+36.3%) | -$44.34M(-65.0%) |
| Mar 2016 | - | -$19.05M(>-9900.0%) | -$26.87M(-20.8%) |
| Dec 2015 | -$37.82M(+5.9%) | $0.00(+100.0%) | -$22.25M(+40.5%) |
| Sep 2015 | - | -$13.16M(-346.4%) | -$37.41M(-4.3%) |
| Jun 2015 | - | $5.34M(+137.0%) | -$35.85M(+32.1%) |
| Mar 2015 | - | -$14.43M(+4.8%) | -$52.81M(-15.4%) |
| Dec 2014 | -$40.19M(-58.7%) | -$15.16M(-30.5%) | -$45.77M(-23.9%) |
| Sep 2014 | - | -$11.61M(+0.1%) | -$36.95M(-14.5%) |
| Jun 2014 | - | -$11.62M(-57.3%) | -$32.26M(+1.6%) |
| Mar 2014 | - | -$7.39M(-16.6%) | -$32.79M(-6.7%) |
| Dec 2013 | -$25.33M(+26.4%) | -$6.33M(+8.5%) | -$30.72M(+7.8%) |
| Sep 2013 | - | -$6.92M(+43.0%) | -$33.32M(+3.2%) |
| Jun 2013 | - | -$12.14M(-128.4%) | -$34.41M(-6.1%) |
| Mar 2013 | - | -$5.32M(+40.5%) | -$32.44M(-1.0%) |
| Dec 2012 | -$34.41M(+35.3%) | -$8.94M(-11.5%) | -$32.13M(+6.2%) |
| Sep 2012 | - | -$8.02M(+21.2%) | -$34.23M(+12.3%) |
| Jun 2012 | - | -$10.18M(-103.5%) | -$39.02M(+9.4%) |
| Mar 2012 | - | -$5.00M(+54.7%) | -$43.09M(+13.1%) |
| Dec 2011 | -$53.17M(-57.1%) | -$11.04M(+13.8%) | -$49.59M(-3.9%) |
| Sep 2011 | - | -$12.80M(+10.1%) | -$47.73M(-4.0%) |
| Jun 2011 | - | -$14.24M(-23.9%) | -$45.92M(-9.3%) |
| Mar 2011 | - | -$11.50M(-25.2%) | -$42.01M(-26.4%) |
| Dec 2010 | -$33.85M(-146.4%) | -$9.19M(+16.4%) | -$33.24M(-270.8%) |
| Sep 2010 | - | -$10.99M(-6.4%) | -$8.96M(-3.4%) |
| Jun 2010 | - | -$10.33M(-278.5%) | -$8.67M(-22.5%) |
| Mar 2010 | - | -$2.73M(-118.1%) | -$7.08M(+48.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | -$13.74M(+49.4%) | $15.09M(+241.0%) | -$13.74M(+27.8%) |
| Sep 2009 | - | -$10.70M(-22.4%) | -$19.02M(-6.3%) |
| Jun 2009 | - | -$8.74M(+6.9%) | -$17.89M(+20.6%) |
| Mar 2009 | - | -$9.39M(-195.7%) | -$22.54M(+17.0%) |
| Dec 2008 | -$27.16M(+15.8%) | $9.80M(+202.4%) | -$27.16M(+32.8%) |
| Sep 2008 | - | -$9.57M(+28.5%) | -$40.40M(+5.4%) |
| Jun 2008 | - | -$13.38M(+4.5%) | -$42.69M(-15.7%) |
| Mar 2008 | - | -$14.02M(-308.9%) | -$36.89M(-14.3%) |
| Dec 2007 | -$32.28M(+31.3%) | -$3.43M(+71.1%) | -$32.28M(+18.5%) |
| Sep 2007 | - | -$11.86M(-56.4%) | -$39.59M(+10.4%) |
| Jun 2007 | - | -$7.58M(+19.4%) | -$44.19M(+7.2%) |
| Mar 2007 | - | -$9.41M(+12.4%) | -$47.62M(-1.4%) |
| Dec 2006 | -$46.98M(-72.9%) | -$10.74M(+34.8%) | -$46.98M(-7.4%) |
| Sep 2006 | - | -$16.46M(-49.4%) | -$43.73M(-24.2%) |
| Jun 2006 | - | -$11.02M(-25.7%) | -$35.20M(-16.9%) |
| Mar 2006 | - | -$8.77M(-17.1%) | -$30.11M(-10.8%) |
| Dec 2005 | -$27.18M(-24.9%) | -$7.49M(+5.5%) | -$27.18M(-8.4%) |
| Sep 2005 | - | -$7.93M(-33.6%) | -$25.06M(-11.0%) |
| Jun 2005 | - | -$5.93M(-1.7%) | -$22.59M(-4.0%) |
| Mar 2005 | - | -$5.83M(-8.5%) | -$21.71M(-0.9%) |
| Dec 2004 | -$21.75M(-59.0%) | -$5.37M(+1.4%) | -$21.52M(-5.6%) |
| Sep 2004 | - | -$5.45M(-7.8%) | -$20.38M(-9.8%) |
| Jun 2004 | - | -$5.06M(+10.4%) | -$18.56M(-9.0%) |
| Mar 2004 | - | -$5.64M(-33.4%) | -$17.02M(-17.6%) |
| Dec 2003 | -$13.68M(+26.9%) | -$4.23M(-16.5%) | -$14.47M(-11.6%) |
| Sep 2003 | - | -$3.63M(-3.2%) | -$12.97M(+1.5%) |
| Jun 2003 | - | -$3.52M(-13.6%) | -$13.16M(+11.6%) |
| Mar 2003 | - | -$3.10M(-13.7%) | -$14.89M(+17.0%) |
| Dec 2002 | -$18.70M(-275.2%) | -$2.72M(+28.8%) | -$17.95M(-17.9%) |
| Sep 2002 | - | -$3.83M(+27.1%) | -$15.23M(-30.0%) |
| Jun 2002 | - | -$5.25M(+14.7%) | -$11.72M(-82.7%) |
| Mar 2002 | - | -$6.16M(>-9900.0%) | -$6.41M(-127.0%) |
| Dec 2001 | -$4.99M(+49.3%) | $0.00(+100.0%) | -$2.83M(+39.5%) |
| Sep 2001 | - | -$314.00K(-670.9%) | -$4.67M(+33.7%) |
| Jun 2001 | - | $55.00K(+102.1%) | -$7.04M(+30.9%) |
| Mar 2001 | - | -$2.57M(-39.3%) | -$10.19M(-48.9%) |
| Dec 2000 | -$9.83M(-21.4%) | -$1.84M(+31.4%) | -$6.84M(-36.8%) |
| Sep 2000 | - | -$2.69M(+13.2%) | -$5.00M(-4.1%) |
| Jun 2000 | - | -$3.10M(-495.8%) | -$4.81M(-111.9%) |
| Mar 2000 | - | $782.40K(>+9900.0%) | -$2.27M(+60.7%) |
| Dec 1999 | -$8.10M(-35.0%) | $0.00(+100.0%) | -$5.77M(+32.0%) |
| Sep 1999 | - | -$2.49M(-345.8%) | -$8.49M(-155.1%) |
| Jun 1999 | - | -$559.00K(+79.5%) | -$3.33M(+42.1%) |
| Mar 1999 | - | -$2.72M(-0.1%) | -$5.75M(+4.6%) |
| Dec 1998 | -$6.00M(+51.2%) | -$2.72M(-201.8%) | -$6.02M(+10.2%) |
| Sep 1998 | - | $2.67M(+189.7%) | -$6.71M(+44.9%) |
| Jun 1998 | - | -$2.98M(+0.8%) | -$12.18M(-4.1%) |
| Mar 1998 | - | -$3.00M(+11.7%) | -$11.70M(+4.1%) |
| Dec 1997 | -$12.30M(-41.4%) | -$3.40M(-21.4%) | -$12.20M(-1.7%) |
| Sep 1997 | - | -$2.80M(-12.0%) | -$12.00M(-3.4%) |
| Jun 1997 | - | -$2.50M(+28.6%) | -$11.60M(-11.5%) |
| Mar 1997 | - | -$3.50M(-9.4%) | -$10.40M(-18.2%) |
| Dec 1996 | -$8.70M(+4.4%) | -$3.20M(-33.3%) | -$8.80M(-11.4%) |
| Sep 1996 | - | -$2.40M(-84.6%) | -$7.90M(-3.9%) |
| Jun 1996 | - | -$1.30M(+31.6%) | -$7.60M(+5.0%) |
| Mar 1996 | - | -$1.90M(+17.4%) | -$8.00M(+11.1%) |
| Dec 1995 | -$9.10M(-33.8%) | -$2.30M(-9.5%) | -$9.00M(-4.7%) |
| Sep 1995 | - | -$2.10M(-23.5%) | -$8.60M(-4.9%) |
| Jun 1995 | - | -$1.70M(+41.4%) | -$8.20M(+2.4%) |
| Mar 1995 | - | -$2.90M(-52.6%) | -$8.40M(-20.0%) |
| Dec 1994 | -$6.80M | -$1.90M(-11.8%) | -$7.00M(-37.3%) |
| Sep 1994 | - | -$1.70M(+10.5%) | -$5.10M(-50.0%) |
| Jun 1994 | - | -$1.90M(-26.7%) | -$3.40M(-126.7%) |
| Mar 1994 | - | -$1.50M | -$1.50M |
FAQ
- What is BioCryst Pharmaceuticals, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. annual EBIT year-on-year change?
- What is BioCryst Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
- What is BioCryst Pharmaceuticals, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. TTM EBIT year-on-year change?
What is BioCryst Pharmaceuticals, Inc. annual earnings before interest & taxes?
The current annual EBIT of BCRX is $11.56M
What is the all-time high annual EBIT for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is $11.56M
What is BioCryst Pharmaceuticals, Inc. annual EBIT year-on-year change?
Over the past year, BCRX annual earnings before interest & taxes has changed by +$129.55M (+109.80%)
What is BioCryst Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of BCRX is $29.59M
What is the all-time high quarterly EBIT for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is $29.79M
What is BioCryst Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
Over the past year, BCRX quarterly earnings before interest & taxes has changed by +$21.90M (+284.70%)
What is BioCryst Pharmaceuticals, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of BCRX is $76.10M
What is the all-time high TTM EBIT for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is $76.10M
What is BioCryst Pharmaceuticals, Inc. TTM EBIT year-on-year change?
Over the past year, BCRX TTM earnings before interest & taxes has changed by +$116.80M (+286.95%)